Ion Trap Collision-Induced Dissociation of Locked Nucleic Acids  by Huang, Teng-yi et al.
Ion Trap Collision-Induced Dissociation of
Locked Nucleic Acids
Teng-yi Huang, Anastasia Kharlamova, and Scott A. McLuckey
Department of Chemistry, Purdue University, West Lafayette, Indiana, USA
Gas-phase dissociation of model locked nucleic acid (LNA) oligonucleotides and functional
LNA-DNA chimeras have been investigated as a function of precursor ion charge state using
ion trap collision-induced dissociation (CID). For the model LNA 5 and 8 mer, containing all
four LNA monomers in the sequence, cleavage of all backbone bonds, generating a/w-, b/x-,
c/y-, and d/z-ions, was observed with no significant preference at lower charge states. Base
loss ions, except loss of thymine, from the cleavage of N-glycosidic bonds were also present.
In general, complete sequence coverage was achieved in all charge states. For the two
LNA-DNA chimeras, however, dramatic differences in the relative contributions of the
competing dissociation channels were observed among different precursor ion charge states.
At lower charge states, sequence information limited to the a-Base/w-fragment ions from
cleavage of the 3=C–O bond of DNA nucleotides, except thymidine (dT), was acquired from
CID of both the LNA gapmer and mixmer ions. On the other hand, extensive fragmentation
from various dissociation channels was observed from post-ion/ion ion trap CID of the higher
charge state ions of both LNA-DNA chimeras. This report demonstrates that tandem mass
spectrometry is effective in the sequence characterization of LNA oligonucleotides and
LNA-DNA chimeric therapeutics. (J Am Soc Mass Spectrom 2010, 21, 144–153) © 2010
American Society for Mass SpectrometrySmall non-coding RNAs, such as small interferingRNAs (siRNAs), microRNAs (miRNAs) andpiwi-interacting RNAs (piRNAs), are involved
in gene regulation in eukaryotic cells. They are the
recognition units of an enzyme/RNA complex (RNA-
induced silencing complexes, RISCs) that lead to
post-transcriptional RNA silencing. Despite their sim-
ilarity in sizes (usually 2030 nucleotides), the func-
tions and mechanisms are distinctive [1, 2]. Efforts have
been devoted to the identification of their target genes
and the cellular functions involved. Several small non-
coding RNAs have been correlated to human diseases.
For example, some miRNAs are involved in the regu-
lation of oncogenes or tumor suppressor genes [3, 4]. A
miRNA, miR-133b, has been identified as a regulator of
the maturation and function of midbrain dopaminergic
neurons involved in Parkinson’s disease [5]. New
classes of small noncoding RNAs continue to be discov-
ered and their functions characterized [6–10]. These
disease-related small RNAs could be potential thera-
peutic targets. Strategically, the functions of certain
small RNAs can either be enhanced by introducing
more copies of the small RNAs or be neutralized by
introducing their antagonists into the cells using anti-
sense techniques. To utilize small RNAs for these ther-
apeutic purposes, major efforts have been directed
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doi:10.1016/j.jasms.2009.09.020toward developing chemically-modified oligonucleo-
tide analogs that can increase the binding specificity
and cellular stability of small RNAs; at the same time,
cytotoxicity and cellular delivery are also major con-
cerns for successful oligonucleotide-based therapeutics.
A variety of nucleotide analogs has been developed and
the effectiveness of the various types as building blocks
of therapeutic small RNAs has been evaluated [1,
11–13].
The locked nucleic acid (LNA) is one of the most
promising nucleic acid analogs. The LNA nucleotides
are RNA analogs that contain a methylene linkage
between the 2= oxygen and the 4= carbon of the ribose
ring. The furanose ring of LNA is locked into an
RNA-like C3=-endo conformation. LNA has a very high
affinity and specificity to its complementary DNA and
RNA. Also, its stability in biological fluids is much
higher due to its increase in nuclease resistance [14, 15].
The LNA-modified oligonucleotides have been used in
several studies for various diagnostic and therapeutic
applications such as single nucleotide polymorphism
analysis [16], transcription factor decoys [17], triple
helix formation and alteration of intron splicing [18],
molecular beacons [19], and direct detection of abortive
RNA transcripts in vivo [20]. LNA has also been em-
ployed to improve the stability and functionality of
siRNAs and RNA aptamers [21, 22]. Stable inhibition of
miRNA functions in nonhuman primates by unconju-
gated LNA-anti-miR oligonucleotides has also been
reported [23]. Currently, several LNA-modified oligo-
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effective therapeutic strategies have been reported us-
ing LNA-containing oligonucleotides. One of them,
called LNA mixmer, has the LNA monomers incorpo-
rated into random positions of an oligonucleotide se-
quence. The mixmers act as antagonists (antisense oli-
gonucleotides) to block the function of a specific RNA
in a stoichiometric manner without the involvement of
RNaseH. The other class of LNA-modified oligonucle-
otide, called LNA gapmer, has a DNA sequence flanked
by two short stretches of LNA on both termini. The
design of the LNA gapmer sequence allows the
RNaseH function to degrade target RNAs [23–26].
These two designs for effective therapeutic LNA-DNA
chimeras hold significant biomedical value in that ei-
ther the decrease or the increase of small noncoding
RNA functions can be achieved.
To use them for therapeutic and diagnostic purposes,
the structural characterization of the synthetic oligonu-
cleotides and/or their metabolites is required. How-
ever, conventional methods are usually not effective for
the structure characterization of highly modified oligo-
nucleotides. On the other hand, mass spectrometry-
based methods are rapid and sensitive alternatives.
Mass spectrometry-based analysis of therapeutic oligo-
nucleotides has been reported in several studies. The
identities of the oligonucleotide-drug and different me-
tabolites can be confirmed by the mass measurements
[27, 28]. Farand and coworkers have demonstrated that
sequence confirmation and de novo sequencing of
highly modified oligonucleotides can be achieved via
mass spectrometry of chemically degraded oligonucle-
otides and tandem mass spectrometry analysis of the
short fragments [29, 30]. However, this method requires
additional sample preparation steps and its efficacy on
LNA-modified oligonucleotides has not been demon-
strated. In comparison to other analytical methods,
tandem mass spectrometry of intact oligonucleotides is
promising for its ability to effectively characterize mol-
ecules of diverse structures without prior chemical or
enzymatic degradation. However, a better understand-
ing of the gas-phase dissociation behavior of the mod-
ified oligonucleotides is a prerequisite. To the best of
our knowledge, few studies have been reported on
tandem mass spectrometry analysis of short modified
oligonucleotides [31–33], and no tandem mass spec-
trometry-based methods to sequence either the LNA or
LNA-containing oligonucleotides have been reported.
Previously, tandem mass spectrometry analysis of sin-
gle strand and duplex siRNAs has been investigated
and full sequence coverage was obtained. However, the
modification is limited to the 3=-terminus DNA over-
hang, and the overall molecules are composed of the
RNA backbone [34]. Considering its unique structure, it
is of interest to study the unimolecular dissociation of
LNA in comparison to DNA and RNA. In this study,
gas-phase dissociation of model LNA oligomers and
two chimeric LNA-DNA oligonucleotides, the LNA
gapmer and mixmer, have been investigated as a func-tion of precursor ion charge states using ion trap
collision-induced dissociation (CID).
Materials and Methods
Methanol, isopropanol, and glacial acetic acid were
purchased from Mallinckrodt (Phillipsburg, NJ, USA).
Ammonium acetate and ethanol were obtained from
Sigma-Aldrich (St. Louis, MO, USA). All LNA oligonu-
cleotides, 5 mer (GCmAGT), 8 mer (ATCmGATCmG),
mixmer (5=-CmcAttGTcaCmaCmtCmCm-3=), and gapmer
(5=-GGGcttcttccttattgATGG-3=), were custom synthe-
sized by Integrated DNA Technologies (Coralville, IA,
USA). (All LNA nucleotides are labeled in upper case;
DNA residues are labeled in lower case). The cytosine
residues in all LNA oligonucleotides were replaced by
methyl cytosine (Cm). The sequence of the mixmer was
chosen based on the work of Elmen et al. [23]. The
sequence of gapmer was chosen based on the work of
Rapozzi et al. [24]. The LNA samples were used with-
out further purification. LNA solutions for negative
nano-electrospray were prepared by diluting the aque-
ous stock solutions to ca. 50 M in 20:80 (vol:vol)
isopropanol:water with the addition of 25 mM piperi-
dine and 25 mM imidazole [35].
All experiments were performed using a prototype
version of a QqTOF tandem mass spectrometer modified
to allow for ion trap CID and ion/ion reaction studies [36].
A home-built pulsed dual nano-electrospray (ESI)
source was coupled directly to the nanospray interface
to produce ions of both polarities [37]. Detailed exper-
imental procedures have been reported previously [34].
In brief, a typical scan function consisted of LNA ion
injection, isolation of the charge states of interest by Q1
in RF/DC mode, ion trap collision-induced dissociation
(CID) in Q2, and then mass analysis by TOF. To remove
charge state ambiguity of the CID product spectra from
dissociation of the higher charge state ions, proton
transfer ion/ion reactions were employed to reduce the
fragment ion charge states. To generate the proton
transfer reagent cations, benzoquinoline was placed
inside of the curtain plate. The benzoquinoline vapor
is subsequently ionized by the nano-ESI generated
positively-charged droplet. To conduct pseudo-MS3 ex-
periments, the LNA anions were fragmented in the
atmosphere/vacuum interface by increasing the poten-
tial difference between the nozzle and skimmer. The
fragment ions of interest were isolated in Q1 and then
subjected to ion trap CID.
Results and Discussion
Ion Trap Collision-Induced Dissociation of
Model LNA Oligomers
LNA is an oligonucleotide analog with exceptional
hybridization affinity toward its complementary DNA
and RNA. The unique structure allows for characteris-
tics suitable for use in the oligonucleotide-based drug
146 HUANG ET AL. J Am Soc Mass Spectrom 2010, 21, 144–153development. While their chemical and physical prop-
erties in the solution phase have been well character-
ized [14, 15, 38], the gas-phase characteristics, such as
stability and unimolecular dissociation chemistry, have
not been investigated. In this study, an LNA 5 mer
(GCmAGT) and an 8 mer (ATCmGATCmG), containing
all four LNAmonomers, i.e., A, T, G, and Cm, were used
as model systems to study the gas-phase dissociation of
LNA upon collisional activation. The dissociation phe-
nomena of the LNA oligomers were investigated as a
function of charge state using ion trap CID.
As shown in Scheme 1 in the supplementary data,
which can be found in the electronic version of this
article, the nomenclature often used for DNA and RNA
dissociation [39] is well-suited for the dissociation of
LNA. For DNA, base losses and the generation of the
a-B/w-ions are the predominant dissociation channels
under collisional activation conditions. For RNA, base
losses and 5= P–O bond cleavage to yield c/y-ions are
the lowest energy dissociation channels, and a-Base/w-
ions, which result from sequential cleavage from the
base loss products, can also be observed when higher
internal energy deposition is achieved. For the gas-
phase dissociation of LNA, four possible cleavage sites
on the phosphodiester backbone can lead to the gener-
ation of four types of characteristic ion pairs, i.e.,
a/w-ions, b/x-ions, c/y-ions, and d/z-ions. The cleav-
age of N-glycosidic bonds leads to nucleobase losses,
 
200 700
200
400
d1
d2
a2b2
c1
c42-
w1 w
x2
y2
b2-Cm
In
te
ns
ity
 (A
rb
. U
ni
t)
d32-
x1
x42-
c2
a2-Cm
200 700 12
1000
2000
d1
d2
a2
a3
b2
b3
c2
c3
w1
w2
w3
x2
x3
y2
y3
z3
a3-Cm
(a
7-C
m
-1
8)
2-
(a
-C
m
)2
-
m
z2
d62-
d3
In
te
ns
ity
 (A
rb
. U
ni
t)
(a
7-C
m
-1
8)
2-
(a
-C
m
)2
-
(a)
(b)
Figure 1. Ion trap tandem mass spectra of
oligonucleotides: (a) product ion spectrum of [M
amplitude of 500 mV (105 kHz); (b) product
ATCmGATCmG, at an excitation amplitude of 1
2H]2 precursor ions. The inset provides a sum
CID of the LNA oligonucleotides.and the subsequent cleavage of the 3= C–O bond from
the base loss ions gives rise to the a-B/w-ions. The
masses of these possible fragment ions were calculated
manually and were then matched against the fragment
ions from the ion trap CID fragment ion spectra.
Figure 1 shows the ion trap tandem mass spectra
of the doubly deprotonated LNA oligonucleotides
(GCmAGT and ATCmGATCmG). In both cases, a large
majority of the product ions could be assigned to
fragment ions expected from backbone cleavages as
well as base loss and subsequent backbone cleavage.
Collisional activation of the doubly deprotonated LNA
led to the cleavage of all backbone bonds, generating
a/w-, b/x-, c/y-, and d/z-ions. No preferential back-
bone bond cleavage was observed consistently for all
linkages. Neutral base losses, except the loss of thy-
mine, were also present. The consecutive loss of neutral
Cm and water was also observed in the CID spectrum.
Unlike DNA, however, base loss was not observed to be
the dominant pathway as backbone cleavages appeared
to be highly competitive with base loss. In comparison
to the dissociation of DNA and RNA, only minimal
abundances of a-Base ions were observed, presumably
due to the relatively stable gas-phase structure of the
base loss ion from LNA. The mechanism for the forma-
tion of the a-Base type ions has been proposed for DNA.
Following the neutral base losses, the abstraction of the
hydrogen from C4 of the ribose ring leads to the
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147J Am Soc Mass Spectrom 2010, 21, 144–153 ION TRAP CID OF LNAssubsequent 3= C–O bond cleavage and the formation of
a furan ring [40]. For LNA, the methylene bridging the
O2=–C4= of the ribose prohibits the formation of a furan
ring after base loss, and therefore inhibits this dissoci-
ation channel. The c/y-ion series, which is the lowest
energy dissociation channel for RNA, is observed for
the dissociation of LNA, but it is not the most favorable
dissociation channel. This result is not surprising since
the presence of the 2= hydroxyl group on the RNA sugar
ring facilitates cleavage of the 5= P–O bond on RNA
[32,41,42]. Hence, the bridging methylene group modi-
fication to the sugar of the LNA removes major factors
that give rise to favored backbone cleavages in both
RNA and DNA. As a result, there appears to be no
strongly favored backbone cleavage channel in the LNA
such that cleavages from a variety of backbone bonds
are observed.
The dearth of a-B ions was further investigated via
pseudo-MS3 experiments. The nano-ESI generated LNA
anions were subjected to fragmentation in the atmo-
sphere/vacuum interface region by nozzle-skimmer
dissociation. To investigate the dissociation behavior of
the base loss ions, the [M  2H  G]2– ion of the LNA
8 mer was isolated and then subjected to ion trap CID
(Figure 2). As shown in Figure 2, although a4-G and
w4-ions, which are generated from the cleavage of the 3=
C–O bond of G, were observed from the pseudo-MS3
spectrum, the two channels were not dominant. Instead,
three major dissociation channels were observed from ion
trap CID of (M  2H  G)2–. Consecutive water losses
(H2O and 2H2O) were the predominant dissociation
channels. Low abundant ions from the subsequent loss of
neutral bases (Cm   (Cm  18)  A0  G0)
were also observed. The secondary backbone bond
cleavages from the (M  2H  G)2– ions also generated
fragment ions observed in the MS2 spectra (a/w, b/x,
c/y and d/z) and extensive fragment -G ions, such as
z3-G, x5-G, a4-G and d6-G. This pseudo-MS3 experi-
ment supports the conclusion that the modification
associated with LNA inhibits the subsequent cleavage
of the 3= C–O bond of the sugar that loses the base,
which is a facile process in both DNA and RNA anions.
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Figure 2. Ion trap tandem mass spectrum of the
at an excitation amplitude of 350 mV (69 kHz).The charge state effect on the gas-phase dissociation
of LNA anions was also investigated. The multiply
deprotonated LNA anions of various charge states
([M  H]– [M  4H]4– of the 5 mer and [M  H]–
[M  5H]5– of the 8 mer) were each isolated and
subjected to ion trap collisional activation under vari-
ous excitation amplitudes (for a summary of observed
dissociation channels, see Figure S-1 in the supplemen-
tary information). Variations in the relative abundances
of different fragment ions were observed for the two
oligonucleotides as a function of charge state. For the
LNA 8 mer, only the d1/z7-ions were observed for the
5= terminal residue and only the a7/w1-ions were
observed for the 3= terminal residue throughout most of
the charge states investigated. For the LNA 5 mer,
however, a wider range of fragment ion types was
observed for both the 5= and 3= terminal residues. Also,
a preference for 5= O–C bond cleavages and the gener-
ation of the d/z-ions at higher charge states was ob-
served for the LNA 8 mer; however, this preference was
not observed for the LNA 5 mer. Qualitatively, however,
very similar dissociation phenomena were obtained
throughout different charge states. Both charged and
neutral base losses were observed together with fragment
ions from almost all possible backbone bond cleavages at
high excitation amplitudes. Full sequence coverage can be
obtained from CID of the LNA 5 and 8 mer.
Ion Trap Collision-Induced Dissociation of
Functional LNA-DNA Chimeras
To evaluate the utility of tandem mass spectrometry in
the structural characterization of modified LNA-DNA
oligonucleotides, the gas-phase dissociation of two
model LNA-DNA chimeras in a linear ion trap mass
spectrometer was investigated, and the charge state
effects were compared. Selection of the sequence of the
LNA gapmer (5=-GGGcttcttccttattgATGG-3=) was in-
spired by the work of Rapozzi et al. [24]. The LNA
gapmer can reduce the transcript level of an oncogene
leading to chronic myeloid leukemia. The sequence of
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148 HUANG ET AL. J Am Soc Mass Spectrom 2010, 21, 144–153the LNA mixmer (5=-CmcAttGTcaCmaCmtCmCm-3=) was
inspired by the work of Elmer et al. [23]. The LNA
mixmer can act effectively as an anti-miRNA to the
liver-specific mir-122. Although the backbone of the
LNA mixmer was either completely or partially modi-
fied by phosphorothioate in the original work, the
oligonucleotides used in this study are composed of
only LNA and DNA monomers. The LNA mixmer was
ionized via nano-ESI in the negative ion mode. Multiply
deprotonated LNA mixmer anions were isolated and
then subjected to ion trap CID. Figure 3 shows the ion
trap CID product ion spectrum of the LNA mixmer
[M  3H]3– ion. Cleavages of the DNA 3=CO bonds
following base losses were the dominant dissociation
channel generating a-B- and w-ions for the LNA
mixmer. Two ions with the mass-to-charge ratios cor-
responding to the y3- and y5-ions were also observed.
However, in general, little evidence for cleavages 3= to
LNA monomer or DNA thymidine was observed.
As has been reported previously, the dissociation of
oligonucleotide anions can be highly sensitive to pre-
cursor ion charge state [43–45]. To investigate the
dissociation behavior of the LNA mixmer anions of
higher charge states, the [M  7H]7– ions were isolated
and subjected to ion trap CID. The interpretation of the
spectrum was facilitated by applying ion/ion proton
transfer reactions, using benzoquinoline cations as the
charge reducing reagent ions [34], to reduce the product
ion charge states to mostly 2- and 1-. As shown in the
post-ion/ion ion trap CID product ion spectrum of the
[M  7H]7– LNA mixmer (Figure 4), significantly
greater structural information resulted from fragmenta-
tion of the higher charge state precursor ion. In addition
to the base loss ions, the a-B/w-ions from the cleavage
of the 3= C–O bond following nucleobase losses from
the DNA residues were still the most preferred disso-
ciation channels, as seen from the relatively high signal
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Figure 3. Ion trap tandem mass spectrum of
amplitude of 600 mV (82.5 kHz). The inset provi
ion trap CID of the [M  3H]3.abundances. Relatively high abundances of the a4/w11-
and a5/w10-ions from the cleavages of the 3= C–O bonds
without the prior losses of thymine were also observed.
Lower but still significant abundances of fragment ions
from other dissociation channels were also present in
the post-ion/ion product ion spectrum. Some of these
ions were from the DNA backbone cleavages, while
others were from the LNA backbone cleavages. It is
apparent that the appearance of either the LNA mono-
mer or DNA thymidine in the oligonucleotide se-
quences can lead to limited backbone cleavages when
precursor anions of low charge are subjected to colli-
sional activation. Fortunately, dissociation of precursor
ions of higher charge states allows access to dissociation
channels that provide more comprehensive primary
sequence information.
Figure 5 shows the ion trap CID product ion spec-
trum of the [M  4H]4– ion of the LNA gapmer
(5=-GGGcttcttccttattgATGG-3=). Similar to the dissocia-
tion of the lower charge state of the LNA mixmer
anions, no backbone bond cleavages from either the
LNA monomers or the DNA thymidines were ob-
served. The a-B/w-ions corresponding to the subse-
quent 3= C–O bond cleavage from the DNA base loss
ions, M-dC, M-dA, and M-dG, were the dominant
sequence ions. In addition, a highly abundant peak at
m/z 785, corresponding to the internal fragmentation
from the cleavage of one glycosidic bond and two 3=
C–O bonds was also observed. This ion, corresponding
to the mass of two thymidines, 5= and 3= phosphate
groups and a furan ring, reflects the high number of
adjacent thymidines in the gapmer sequence. It can be
either the a-B ion from one of the w ions of the
precursor ion or the w ion from one of the a-B ions of
the precursor ion. There are other unidentified second-
ary fragment ions of lower abundance as well. Due to
the high content of LNAmonomer and DNA thymidine
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tively low precursor ion charge state is limited.
The gas-phase dissociation behavior of the LNA gap-
mer at higher charge state was further investigated. Figure
6 shows the post-ion/ion ion trap CID product ion spec-
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Figure 4. Post-ion/ion ion trap CID spectrum
correspond to mass range m/z 2001700 and 170
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Figure 5. Ion trap tandemmass spectra of (M
of 700 mV (79 kHz). : internal fragmentation. T
resulting from ion trap CID of the [M  4H]4.trum of the [M  9H]9– LNA gapmer. In contrast to the
dissociation of [M  9H]4– (Figure 5), extensive backbone
bond fragmentationwas observed for the LNAgapmer. In
addition to the a-B/w-ions, extensive cleavage of the 5=
P–O bond in the DNA region of the LNA-DNA gapmer
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151J Am Soc Mass Spectrom 2010, 21, 144–153 ION TRAP CID OF LNAsThe backbone of an oligonucleotide on the 3= side of
a sugar with the LNA modification is stabilized with
respect to fragmentation, relative to RNA and DNA
residues. In the LNA modified species, the 2= hydroxyl
group is converted to an ester, which precludes the
facile mechanism in RNA that yields complementary
c/y-ions, and the 4= hydrogen normally present in
unmodified sugars, which is necessary for the facile 3=
C–O bond cleavage from base loss ions to yield a-Base/
w-ions is replaced by a methylene group in the LNA
sugar. As a result of these differences, there are no
particularly low-energy backbone dissociation path-
ways for the LNA residues so that cleavages at all
backbone bonds are more competitive with one an-
other. However, when there are mixed residue types,
those with the LNA modification do not compete with
unmodified residues. In this work, the unmodified
residues were DNA nucleotides. The LNA backbone
bonds are generally more resistant to gas-phase disso-
ciation than DNA. In addition, loss of nucleobase from
LNA monomer lead to mostly consecutive water losses,
base losses and low abundant secondary fragment ions.
Similar observations would be expected for RNA nu-
cleotides as the mechanism that gives rise to c/y-ions
has been noted to be a lower energy process than that
giving rise to a-B/w-ions [45].
The richer array of sequence informative ions gener-
ated from the more highly charged precursor ions
might reflect a role for electrostatic repulsion in weak-
ening backbone bonds in such a way as to make a wider
variety of dissociation channels more competitive. As
charge increases, one of the mechanisms for the forma-
tion of a-B/w-ions is also expected to be less important.
At moderate to low charge states, for example, proton
transfer from a neutral phosphodiester linkage to a
nucleobase has been proposed to precede base loss
[46–48]. This is consistent with the minimal loss of
thymine, which has a significantly lower proton
affinity than the other nucleobases, observed from the
T-containing anions examined here. Loss of thymine as
an anion, however, has been noted to be competitive to
losses of other charged bases in oligonucleotide anions
with most of the phosphodiester linkages being
charged. In the case of the gapmer, the [M  9H]9–
precursor ion gave much more sequence information
than the [M  4H]4– ion but in neither case were most
of the phosphodiester linkages (20 are present in the
gapmer studied here) charged. The [M  9H]9– was the
most highly charged abundant ion in the electrospray
mass spectrum of the gapmer. No concerted efforts
were made to generate ions of higher charge state.
However, if it were possible to generate ions of
higher charge state, there is the possibility that some
fragmentation from the LNA residues might be more
competitive.
In practice, ion trap CID of the LNA-DNA chimeras of
lower charge states provides simple and predictable se-
quence specific fragment ions, which is analogous to the
restriction enzyme digestion of oligonucleotides. The dis-sociation pattern provides an additional measurement for
the accurate synthesis of the oligonucleotide-based thera-
peutics in addition to their molecular masses. The pre-
ferred dissociation channels are dependent on the types
of nucleotide monomer (i.e., the backbone bonds of dA,
dG, and dC tend to dissociate more easily than those of
dT and the LNA monomers) and more-or-less indepen-
dent of their positions. Consequently, depending on the
composition of the oligonucleotides, higher sequence
coverage can be obtained when the major components
are DNA (dA, dG, and dC). Since the spectra are
relatively simple, the oligonucleotide sequences can
be confirmed without conducting the experiment in a
high-performance mass spectrometer. On the other
hand, ion trap CID of the higher charge state precur-
sor ions usually gives rise to higher sequence cover-
age. However, multiply deprotonated fragment ions
from various dissociation channels together with
abundant secondary fragmentation may complicate
the spectra, which is a major tradeoff. Therefore,
mass spectrometers of higher performance may be
needed. In this study, it has been demonstrated that
the tandem mass spectrometry analysis is effective
for the sequence characterization of intact functional
LNA-DNA oligonucleotides.
Conclusions
In this study, the dissociation behavior of LNA anions
under ion trap collisional activation conditions has been
investigated. Unlike DNA and RNA anions, no prefer-
ential dissociation channels were observed for LNA
anions. The majority of the fragment ions resulted from
the losses of nucleobases and various backbone bond
cleavages with no significant preference. On the other
hand, sequence characterization of the LNA-DNA chi-
meras was more complicated under ion-trap CID con-
ditions. The backbone bonds of the LNA subunits are
much more stable than those of the DNA subunits at
lower charge states due to the nature of the sugar
modification. Therefore, the fragment ions were mostly
generated from the preferred dissociation of DNA
nucleobase losses and the subsequent 3= C–O bond
cleavages when both LNA and DNAmonomers were in
the sequence; while the backbone bond dissociation
from the LNA units was minimal. However, at higher
charge states and with higher activation amplitudes,
more sequence informative cleavages were noted in
general. Overall, the major factors observed here that
affect the extent of sequence information include the
identities of the residues, with LNA and DNA dT
residues being most resistant to cleavage, precursor ion
charge state, and activation amplitude.
The development of oligonucleotide-based therapeu-
tics is a fast growing research field. While strategies
have been devised to develop more stable and effective
oligonucleotide drugs, which involve incorporating dif-
ferent types of modifications at different positions, the
sequence composition of these types of oligonucleotides
152 HUANG ET AL. J Am Soc Mass Spectrom 2010, 21, 144–153are more complex. However, conventional methods for
oligonucleotide sequencing are ineffective in character-
izing these modified molecules. To analyze these mol-
ecules using tandem mass spectrometry, a better under-
standing of the gas-phase stability of different modified
nucleotide analogs is desirable. The present study dem-
onstrates that tandem mass spectrometry using ion trap
CID can be effective in the structural characterization of
LNA-based therapeutic oligonucleotides and highlights
the important role the sugar structure plays in deter-
mining preferred backbone dissociation channels.
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